TSC1 and tuberous sclerosis: It is not known which functions of TSC-Rheb-TOR in the nervous system are mediated by either or both of the two Tor kinase-containing complexes, and if pharmacological intervention in tuberous sclerosis complex patients should best be directed at TORC1, with agents such as rapamycin, or if TORC2-specific agents will also be important.